Company
Who we are
Alvotech is a privately owned, fully integrated specialty biopharmaceutical company focused exclusively on the development and manufacturing of high-quality biosimilar products ...
Company
WHAT WE DO
Our biosimilar assets include several biosimilar monoclonal antibodies and fusion proteins that are developed in our research & development centers located across Europe and are manufactured in our state-of-the-art facility in Reykjavik, Iceland ...
Newsroom
Alvotech is warming up for CPhI 2019 in Frankfurt
This promises to be a busy and exciting fall for Alvotech. Once more it will be participating in the world's largest pharmaceutical fair, CPhI, which this year is being hosted in Frankfurt, Germany, from 5-7 November 2019.
Meet management
World Class team
Alvotech brings together a group of world-class pharmaceutical executives with broad backgrounds and extensive experience in the biopharmaceutical industry. The leadership team is led by Alvotech’s CEO Mark Levick and the company’s founder Robert Wessman ...
Partnerships
Partnering with Alvotech is gaining access to high quality, ready to market biosimilars